Abstract
In the series of Ul Haq et al ( 1 Ul Haq F. Mitchell S.E. Tekes A. Weiss C.R. Bleomycin foam treatment of venous malformations: a promising agent for effective treatment with minimal swelling. J Vasc Interv Radiol. 2015; 26: 1484-1493 Abstract Full Text Full Text PDF Scopus (29) Google Scholar ), 20 patients underwent 21 bleomycin foam embolization procedures, and six procedures involved sclerosant agents in additional to bleomycin. The authors report a per-patient complication rate of 40% (30% minor, 10% major); on a per-procedure basis, the complication rate was 29% (22% minor, 7% major). The authors state that all patients had a decrease in symptoms after treatment. Bleomycin Foam Treatment of Venous Malformations: A Promising Agent for Effective Treatment with Minimal SwellingJournal of Vascular and Interventional RadiologyVol. 26Issue 10PreviewTo report clinical and radiographic outcomes of patients with venous malformations (VMs) treated with bleomycin foam. Full-Text PDF
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
